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The transduction signals from the immobilisation of a class I
heavy chain, HLA-A2, on a layer guided acoustic plate mode
device, followed by binding of b2-microglobulin and subsequent
selective binding of a target peptide are reported.
Two key areas of investigation in immunology are Major
Histocompatibility Complex (MHC)–peptide interactions and
the construction and use of artificial systems for antigen presenta-
tion to T-lymphocytes (T cells). The MHC codes for a family of
proteins that play a critical role in immune responses to cellular
proteins and proteins derived from foreign organisms. MHC
molecules bind peptide fragments derived from naturally processed
proteins and display them on the surface of cells for recognition by
T cells. In man there are 2 main classes of MHC: (HLA) class I
antigens expressed on the surface of all nucleated cells and class II
antigens which have a restricted expression profile and are found
mainly on cells capable of antigen presentation. When expressing
immunogenic peptides, class I and class II MHC molecules
stimulate cytotoxic T-cell and T-helper cell responses respectively.
HLA class I antigens are comprised of a HLA heavy chain and
b2m which is non-covalently linked. Peptides associated with this
complex are then presented for recognition by the T-cell receptor
expressed by T-lymphocytes and subsequently promote antigen-
specific T-cell immune responses.
Potentially the changes in conformation as the HLA heavy
chain refolds with its attendant partners may be detectable by a
shift in the response of a surface sensitive resonant device. In
particular, our interest is whether an acoustic wave response can
provide both a quantification of the amount of peptide binding to
the HLA and an estimate of the time for it to occur. An acoustic
wave sensor suitable for this purpose operates in a liquid with high
sensitivity to binding. This suggests a Love wave device, which uses
a shear horizontal mode of oscillation with a guiding layer to
obtain maximum sensitivity.1 However, such a device has the
guiding layer on the same face of the substrate as the inter-digital
transducers (IDT) used for the generation and detection of the
wave and both of these are also on the substrate face used for the
binding specific surface chemistry. An alternative is to use a shear
horizontal acoustic plate mode (SH-APM), which may be excited
and detected by IDTs fabricated on the opposite face of the sub-
strate to that used for sensing,2,3 but this exhibits a lower sensitivity
than Love waves.4 Recently, McHale et al.5,6 suggested from
theoretical considerations that a guiding layer could be used on
one substrate face of a SH-APM device to create a layer guided
acoustic plate mode (LG-APM) and so obtain a sensitivity appro-
aching that of a Love wave. Recently, Evans et al.7 demonstrated
experimentally that lithium tantalate substrates could be used for a
LG-APM, thus creating the possibility of using opposing substrate
faces to separate the layer providing enhanced sensitivity from that
for the binding specific surface chemistry.
SH-APM devices were fabricated on 36u rotated Y-cut X
propagating lithium tantalate substrates of thickness 540 mm with
the underside of the wafers polished. The IDTs were a double–
double finger design with 100 fingers, finger width and spacing of
20 mm and an aperture of 3000 mm; the distance from centre-to-
centre of IDTs was 12 mm and the fingers consisted of 40 nm of
titanium followed by 200 nm of gold. The fundamental frequency
of the device was 26.3 MHz and a series of plate mode resonances
were observed at 27.8, 29.5, 32.0, 36.2, 39.8, 43.6 and 47.6 MHz.
Guiding layers of S1813 photoresist were spun onto either the
upper-side or the under-side of the substrates at 1000 rpm for
5 seconds and then 4000 rpm for a further 30 seconds; the layers
were then cross-linked by heating for 1 hour at 105 uC. Sensitivity
measurements were made by depositing thin layers of gold in the
form of a 4 mm wide stripe between the IDTs on to the guiding
layer and monitoring the spectra of the devices using a network
analyser; the resonant frequency was determined as the minimum
in insertion loss for the different peaks. These measurements were
used to choose a guiding layer thickness for optimum sensitivity in
the biosensing experiments, which used a flow cell with a path
length of 4 mm. Whilst the upper-side of the acoustic wave device
could be used as the sensing side, in these experiments we used the
under-side to apply a photoresist guiding layer and the upper-side,
containing the IDTs, for a separate sensing layer of polystyrene on
to which the MHC–peptide immobilisation was performed.
The immobilisation method was based on the strong non-
covalent avidin–biotin interaction8 and involved the addition of a
photoactivatable biotin residue onto a polystyrene surface; poly-
styrene has previously been shown to be robust in the presence of
buffer liquids.9 The polystyrene layer of thickness 1.87 mm was spin
coated at 860 rpm in a 10 mg ml21 solution in toluene. Following
deposition the layer was cleaned by exposure to ozone for
30 minutes. Once the device had been coated with polystyrene, the
photobiotin acetate (Sigma Chemicals) in a solution of 10 mg ml21
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ethanol–water 20 : 80% was applied and left overnight under
nitrogen after which it was fixed in place by exposure to UV; the
surface was then able to bind the streptavidin (molecular weight of
55–60 kDa). The LG-APM device was then placed into a flow cell
into which was passed phosphate buffered saline (PBS) 20 mM
drawn across by a peristaltic pump at 0.4 ml min21 and the
acoustic phase was monitored until a stable signal was achieved.
Solutions were temperature equilibrated prior to being introduced
to the device surface via a slow flow system with a 10 cm path length.
Initial studies looked at introducing streptavidin at 0.1 mg ml21
and following this with biotinylated HLA-A2 heavy chain10 at
0.3 mg ml21; the molecular weight of the HLA-A2 is 45 kDa.
However, this did not produce reliable results and an approxi-
mately 2-to-1 cocktail of streptavidin (0.15 mg ml21, Sigma
Chemicals) and biotinylated HLA-A2 heavy chain (0.3 mg ml21)
was introduced. The resulting sensor surface is shown schemati-
cally in Fig. 1(a); since streptavidin has four biotin binding sites,
this procedure will produce a mixture of surface bound
streptavidin with between one and four binding sites linking to
the sensor surface and the remaining sites binding with the
HLA-A2 heavy chain. At this stage the HLA-A2 heavy chain is
unfolded and the a2 and a3 constituent domains remain flexible.
The binding of each component (biotin and then streptavidin) via
this approach was confirmed by fluorescence microscopy. The next
stage was to challenge the sensor with 0.3 mg ml21 of b2m
11 to
initiate partial refolding of the heavy chain thus initiating the
formation of the peptide binding cleft; b2m has a molecular weight
of 11.5 kDa. At this stage the b2m and HLA-A2 molecule is still
relatively unstable and can disassociate easily; a schematic of the
sensor in this configuration is shown in Fig. 1(b). This system of
HLA-A2 heavy chain and b2m was then challenged with the CMV
derived pp65 NLVPMVATV–peptide (molecular weight of
0.95 kDa), which is known to bind strongly, and also with a
b-galactosidase peptide epitope TPHPARIGL that binds only
weakly with the MHC (Fig. 1(b)). After peptide binding has
occurred the molecule attains its final conformation with all
components more rigidly bound. Fig. 1(b) shows a schematic of
the complete sensor including the transduction components of the
sensor comprising of the photoresist guiding layer on the lower
substrate face of the lithium tantalate (to increase sensitivity) and
the IDT’s used to launch and receive the acoustic wave; The biotin
linked polystyrene–streptavidin–HLA-A2–b2m structure provides
the peptide specific binding surface chemistry.
A first set of experiments was used to assess the relative mass
sensitivities provided by guiding layers on opposing faces of the
substrate and, hence, to select an operating guiding layer thickness.
Fig. 2(a) shows the change in resonant frequency of a 47.6 MHz
plate mode as gold is deposited on to a guiding layer of thickness
14 mm. In this figure, the diamonds show the effect of the gold
deposited on a guiding layer on the upper face containing the IDT
and the squares show the effect of the gold deposited on a guiding
layer on the opposite (lower) face; in both cases only one face of
the substrate was coated. The gradients from Fig. 2(a) are
6.5 kHz nm21 (upper face guiding layer) and 6.2 kHz nm21 (lower
face guiding layer) for an effective sensing area of 0.12 cm2
suggesting that similar sensitivity is achieved for a guiding layer
on either face; this corresponds to frequency sensitivities of
336 Hz (ng mm22)21 and 321 Hz (ng mm22)21. To systematically
determine the optimum guiding layer thickness, this procedure
Fig. 1 Schematic of sensor: (a) substrate with streptavidin–biotin binding
to unfolded HLA-A2 chain and with biotin binding to polystyrene layer to
link to the acoustic wave sensor; (b) binding of b2m causing partial
refolding with subsequent binding of peptide sensed by the acoustic wave.
Fig. 2 (a) Change in resonant frequency of the 47.6 MHz mode as a
function of thickness of gold deposited on the guiding layer. The diamonds
show data for the guiding layer on the IDT face and the squares for the
guiding layer on the opposite face. (b) Sensitivity calculated from the
gradients in Fig. 2(a) as a function of guiding layer thickness.
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was repeated for guiding layer thicknesses up to 44 mm;
Fig. 2(b) summarizes the resulting dependence of sensitivity on
guiding layer thickness. These values are comparable with
traditional APM sensors3 operating at several times the frequency
used for our LG-APM, thus confirming the gain in sensitivity
from the use of a guiding layer. From these data a guiding layer
thickness of 14 mm, corresponding to the peak in sensitivity for the
first guided mode, was chosen for the subsequent bio-sensing
experiments. Based on the measured frequency sensitivity of
321 Hz (ng mm22)21 and using an estimate of the wavelength of
the 47.6 MHz plate mode of 100 mm, the phase sensitivity of the
system is y0.1 degrees per ng mm22.
The bio-sensing experimental sequence was initiated by the
introduction of the streptavidin and HLA-A2 heavy chain together
to the sensing surface, then pausing the pump for a period of
approximately 30 minutes followed by restarting the flow system
with buffer. Subsequently, the b2m was introduced and this
produced an approximately 1u fall in the acoustic phase (Fig. 3(a)
at 830 s). At 1430 s the pump was switched off to allow the surface
to be in contact with the b2m and the pump was then restarted
with buffer at 2873 seconds. The b2m binds to the HLA-A2 heavy
chain causing partial refolding of the A2 (Fig. 1(b)). Given the
relative size of the b2m, which is a small protein of molecular
weight 11.5 kDa, we believe the ability of the sensor to detect the
change in phase by a mass loading response is marginal. Assuming
the streptavidin forms a rigidly packed monolayer with typical
molecular diameter of 84 A˚12 the surface mass density can be
estimated as Dms y 1.8 ng mm
22. Using an average of two HLA
and hence two b2m per streptavidin then suggests a surface mass
density for the b2m of Dmb2m y 0.7 ng mm
22 and this implies an
acoustic wave phase change y 0.07u based on the sensitivity
determined from Fig. 1(b); this is an order of magnitude less than
observed in Fig. 3(a). The conformational changes taking place as
the HLA-A2 heavy chain partially refolds (i.e. the transition
shown schematically from Fig. 1(a) to Fig. 1(b)) may therefore be
the cause of the change in phase.
The subsequent change of phase as the NLVPMVATV–peptide
is introduced to this system is shown in Fig. 3(b). Although
thermal drift on the data is present, the sharp change upon
introduction of the peptide was repeatable. The molecular weight
of the peptide is 0.95 kDa, which is around 8% of the molecular
weight of the b2m, but nevertheless we observe a similar size phase
change as occurred upon the introduction of the b2m and this is
strongly indicative of a non-mass loading response. Since it is
expected that the MHC should respond to this particular peptide
entering the binding cleft by completely folding and the
components becoming more rigidly bound, we believe this
conformational change could be the cause of the measured phase
change. To verify whether the binding was peptide specific, the
experimental procedure was repeated with the last stage using a
TPH epitope that binds only weakly with the MHC and no phase
shift was observed in this case (exemplar data provided in the
electronic supplementary information{).
In this study we have demonstrated that guiding layers on an
acoustic plate mode device can be used to enhance the sensitivity
without losing the advantages of the traditional APM. The
application of the layer guided APM device as a biosensor has
been demonstrated by monitoring the formation of an HLA
molecule from an immobilised HLA-A2 heavy chain and the
addition of b2m to create a partially refolded product. The
subsequent binding of a peptide with a known affinity has then
been observed. The signal response has been interpreted to be a
consequence of a conformational change because a simple mass
attachment would be expected to provide an acoustic response
lower than the detection threshold. A similar experiment with a
weakly binding peptide showed no detectable change. We have
therefore demonstrated that LG-APMs provide potential for
real time monitoring of MHC–peptide interactions. The use of a
higher fundamental frequency LG-APM to increase the sensitivity
should allow this approach to become a tool for assessing protein–
protein/protein–peptide binding.
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